SU-E-J-63: Feasibility Study of Proton Digital Tomosynthesis in Proton Beam Therapy

2012 ◽  
Vol 39 (6Part7) ◽  
pp. 3666-3667
Author(s):  
B Min ◽  
J Kwak ◽  
J Lee ◽  
S Cho ◽  
S Park ◽  
...  
Keyword(s):  
Proton Beam ◽  
Feasibility Study ◽  
Proton Beam Therapy ◽  
Digital Tomosynthesis

A feasibility study of a hybrid breast-immobilization system for early breast cancer in proton beam therapy

2017 ◽  
Vol 44 (4) ◽  
pp. 1268-1274 ◽  
Author(s):  
Takeshi Arimura ◽  
Takashi Ogino ◽  
Takashi Yoshiura ◽  
Mitsugi Matsuyama ◽  
Naoaki Kondo ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Proton Beam ◽  
Early Breast Cancer ◽  
Feasibility Study ◽  
Proton Beam Therapy

scholarly journals A prospective feasibility study of respiratory-gated proton beam therapy for liver tumors

2014 ◽  
Vol 4 (5) ◽  
pp. 316-322 ◽  
Author(s):  
Theodore S. Hong ◽  
Thomas F. DeLaney ◽  
Harvey J. Mamon ◽  
Christopher G. Willett ◽  
Beow Y. Yeap ◽  
...  
Keyword(s):  
Proton Beam ◽  
Feasibility Study ◽  
Liver Tumors ◽  
Proton Beam Therapy

Applications of Proton Digital Tomosynthesis in Proton Beam Therapy

2012 ◽  
Vol 84 (3) ◽  
pp. S54
Author(s):  
B. Min ◽  
J. Kwak ◽  
J. Lee ◽  
S. Cho ◽  
S. Park ◽  
...  
Keyword(s):  
Proton Beam ◽  
Proton Beam Therapy ◽  
Digital Tomosynthesis

scholarly journals Phase II Feasibility Study of High-Dose Radiotherapy for Prostate Cancer Using Proton Boost Therapy: First Clinical Trial of Proton Beam Therapy for Prostate Cancer in Japan

2005 ◽  
Vol 35 (12) ◽  
pp. 745-752 ◽  
Author(s):  
Keiji Nihei ◽  
Takashi Ogino ◽  
Satoshi Ishikura ◽  
Mitsuhiko Kawashima ◽  
Hideki Nishimura ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Clinical Trial ◽  
Proton Beam ◽  
Feasibility Study ◽  
Phase Ii ◽  
Proton Beam Therapy ◽  
High Dose

Complications after Proton Beam Therapy to Skull Base Tumors: Case Series

2019 ◽  
Author(s):  
Gustavo Rangel ◽  
Mostafa Shahein ◽  
Thiago Felicio ◽  
Guilhermo Malave ◽  
Nyall London ◽  
...  
Keyword(s):  
Skull Base ◽  
Proton Beam ◽  
Case Series ◽  
Proton Beam Therapy ◽  
Skull Base Tumors

Proton Beam Therapy for Unresectable Adenoid Cystic Carcinoma of the Skull Base

Skull Base ◽  
2008 ◽  
Vol 18 (S 01) ◽  
Author(s):  
Annie Chan ◽  
Paul Busse ◽  
Urmila Kamat ◽  
Derrick Lin ◽  
Norbert Liebsch
Keyword(s):  
Adenoid Cystic Carcinoma ◽  
Skull Base ◽  
Proton Beam ◽  
Proton Beam Therapy ◽  
Adenoid Cystic

scholarly journals Feasibility of Proton Beam Therapy as a Rescue Therapy in Heavily Pre-Treated Retinoblastoma Eyes

Cancers ◽  
2021 ◽  
Vol 13 (8) ◽  
pp. 1862
Author(s):  
Eva Biewald ◽  
Tobias Kiefer ◽  
Dirk Geismar ◽  
Sabrina Schlüter ◽  
Anke Manthey ◽  
...  
Keyword(s):  
Proton Beam ◽  
Rescue Therapy ◽  
Therapeutic Option ◽  
Proton Beam Therapy ◽  
External Beam Radiation ◽  
Time Interval ◽  
Beam Radiation ◽  
Primary Tumors ◽  
Increased Risk

Despite the increased risk of subsequent primary tumors (SPTs) external beam radiation (EBRT) may be the only therapeutic option to preserve a retinoblastoma eye. Due to their physical properties, proton beam therapy (PBT) offers the possibility to use the effectiveness of EBRT in tumor treatment and to decisively reduce the treatment-related morbidity. We report our experiences of PBT as rescue therapy in a retrospectively studied cohort of 15 advanced retinoblastoma eyes as final option for eye-preserving therapy. The average age at the initiation of PBT was 35 (14–97) months, mean follow-up was 22 (2–46) months. Prior to PBT, all eyes were treated with systemic chemotherapy and a mean number of 7.1 additional treatments. Indication for PBT was non-feasibility of intra-arterial chemotherapy (IAC) in 10 eyes, tumor recurrence after IAC in another 3 eyes and diffuse infiltrating retinoblastoma in 2 eyes. Six eyes (40%) were enucleated after a mean time interval of 4.8 (1–8) months. Cataract formation was the most common complication affecting 44.4% of the preserved eyes, yet 77.8% achieved a visual acuity of >20/200. Two of the 15 children treated developed metastatic disease during follow-up, resulting in a 13.3% metastasis rate. PBT is a useful treatment modality as a rescue therapy in retinoblastoma eyes with an eye-preserving rate of 60%. As patients are at lifetime risk of SPTs consistent monitoring is mandatory.

Sign in / Sign up

Export Citation Format

Share Document